FDA drug shortage database — GLP-1 receptor agonist products
Shortage status for approved GLP-1 products materially affects this market: when an approved product is listed as in shortage, compounding of that substance becomes permissible under conditions, and demand shifts toward alternative supply. Resolution of a shortage reverses that. PepIndex records status changes here because they move the whole category.
Placeholder record
This entry records a standing source rather than a dated action. It is kept out of search indexes until it is replaced by a full record.
Source
https://www.accessdata.fda.gov/scripts/drugshortages/The issuing body’s own page is authoritative. PepIndex records what it says and when we recorded it; where the two disagree, the source governs.
Compounds affected
Ranked vendors for Semaglutide
Every vendor and price for Semaglutide →- 1
Amino Club$5.00/mg listed · 0 Semaglutide certificates90.1of 100Extensively documentedVisit Amino Club - 2
Ascend Science1 Semaglutide certificate88.9of 100Extensively documentedVisit Ascend Science - 3NLNorthline Labs$4.50/mg listed · 1 Semaglutide certificate87.7of 100Extensively documentedVisit Northline Labs
Ranked on this compound's price per mg against the market median, with testing and documentation counted as they are overall. A regulatory action against a vendor is recorded on that vendor's profile and counts against its score.
Ranked vendors for Tirzepatide
Every vendor and price for Tirzepatide →- 1
Origin Labs1 Tirzepatide certificate96.9of 100Extensively documentedVisit Origin Labs - 2
Next Gen Peptides$2.00/mg listed · 12 Tirzepatide certificates93.6of 100Extensively documentedVisit Next Gen Peptides - 3Ascend Science$4.55/mg listed · 6 Tirzepatide certificates92.9of 100Extensively documentedVisit Ascend Science
Ranked on this compound's price per mg against the market median, with testing and documentation counted as they are overall. A regulatory action against a vendor is recorded on that vendor's profile and counts against its score.